Affimed N.V. (AFMD)
NASDAQ: AFMD · IEX Real-Time Price · USD
5.15
-0.29 (-5.33%)
At close: Jul 19, 2024, 4:00 PM
5.11
-0.04 (-0.78%)
Pre-market: Jul 22, 2024, 4:24 AM EDT

Affimed Revenue

Affimed had revenue of $4.26M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $168.48K. In the year 2023, Affimed had annual revenue of $9.19M.

Revenue (ttm)
$4.26M
Revenue Growth
-89.65%
P/S Ratio
18.41
Revenue / Employee
$56,064
Employees
76
Market Cap
78.42M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.19M-34.80M-79.10%
Dec 31, 202243.99M-1.88M-4.09%
Dec 31, 202145.87M11.29M32.63%
Dec 31, 202034.59M10.55M43.90%
Dec 31, 201924.03M-3.25M-11.90%
Dec 31, 201827.28M24.87M1,031.03%
Dec 31, 20172.41M-4.23M-63.70%
Dec 31, 20166.64M-1.57M-19.10%
Dec 31, 20158.21M4.12M100.71%
Dec 31, 20144.09M-2.90M-41.50%
Dec 31, 20137.00M5.45M352.11%
Dec 31, 20121.55M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Protalix BioTherapeutics 59.65M
Alpha Teknova 36.85M
DBV Technologies 14.94M
Hyperfine 11.69M
Chimerix 41.00K
Revenue Rankings